# OnCo record oral-tongue-cancer (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/oral-tongue-cancer/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "oral-tongue-cancer" ;
  schema:name "Oral tongue and floor of mouth cancer"@en ;
  schema:alternateName "Tongue cancer"@en, "Anterior two-thirds of tongue cancer"@en, "Floor of mouth cancer"@en, "Oral tongue squamous cell carcinoma"@en ;
  schema:description "Cancer of the front of the tongue or the floor of the mouth is treated first with surgery, and a Tata Memorial trial settled that the neck lymph nodes should be removed at the same operation even when scans look clear. How deep the tumour has grown is now the number that decides staging and the need to treat the neck."@en ;
  schema:url <https://onco.cc/cancers/oral-tongue-cancer/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Oral_cancer> ;
  schema:citation <https://en.wikipedia.org/wiki/Oral_cancer> ;
  onco:tag "subtype-page", "head-and-neck" ;
  onco:drugs <https://onco.cc/drugs/celecoxib/> ;
  onco:terms <https://onco.cc/terms/extranodal-extension/>, <https://onco.cc/terms/depth-of-invasion/>, <https://onco.cc/terms/cdkn2a-homozygous-deletion/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-dcruz-elective-neck-dissection-nejm-2015/>, <https://onco.cc/key-papers/paper-keynote-048-lancet-2019/>, <https://onco.cc/key-papers/paper-bernier-eortc-22931-nejm-2004/> ;
  onco:pipeline <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/trials/keynote-689/>, <https://onco.cc/technologies/sentinel-node/>, <https://onco.cc/trials/nivopostop/> ;
  onco:standardOfCare <https://onco.cc/technologies/pet-ct/>, <https://onco.cc/trials/elective-neck-dissection-tmh/>, <https://onco.cc/technologies/sentinel-node/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/trials/keynote-048/>, <https://onco.cc/drugs/methotrexate/>, <https://onco.cc/trials/metronomic-vs-cisplatin-tmh/>, <https://onco.cc/cancers/recurrent-metastatic-hnscc/>, <https://onco.cc/technologies/smoking-cessation-after-diagnosis/>, <https://onco.cc/technologies/alcohol-reduction-labelling/>, <https://onco.cc/technologies/oral-visual-screening/> .